Glioblastoma / Anaplastic Astrocytoma Case Study

Pharm-Olam is currently partnering with a sponsor company in the development of a treatment for Glioblastoma / Anaplastic Astrocytoma. This type of brain tumor has very few available therapies, so this study’s goal is to assist in potentially identifying additional effective treatment options.

Study Overview:
A Phase II/III study for the treatment of Recurrent Glioblastoma / Anaplastic Astrocytoma

Sites & Locations:
60 across North America, Western Europe, and the Middle East

Services Provided:
• Regulatory
• Monitoring
• Project Management
• Quality Assurance

Learn the details by clicking on the image on the right.

Glioblastoma / Anaplastic Astrocytoma Case Study